Infection by SARS-CoV-2, the virus that causes COVID-19, may trigger cold agglutinin disease (CAD) in adults, according to a small…
Articles by Patricia Inácio, PhD
Investment for rare diseases, such as cold agglutinin disease (CAD), has seen a growing interest by investors, outmatching that…
SARS-CoV-2, the virus that causes COVID-19, may trigger cold agglutinin disease (CAD) in children, a case report suggests. The…
Ahead of this year’s Rare Disease Week on Capitol Hill, held virtually July 14–22, the EveryLife Foundation will…
Symptoms of cold agglutinin disease (CAD) worsened for a 57-year-old woman two days after receiving the first dose of…
More than half of the people with rare diseases and their caregivers, asked in a survey, were undecided or less…
The EveryLife Foundation for Rare Diseases is accepting applications for a scholarship program that aims to help adults with a…
COVID-19 can be associated with the development of cold agglutinin disease (CAD), leading to the need for blood…
Coronavirus disease 2019 (COVID-19) could cause cold agglutinin disease (CAD), a case report of two…
Japanese patients with cold agglutinin disease (CAD) are almost three times more likely to develop blood clots compared with people…